(Q48569673)

12 February 2018

title

Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal. (English)

1 reference

12 February 2018

author name string

Howard C Becker

series ordinal

1

1 reference

12 February 2018

Hugh Myrick

series ordinal

2

1 reference

12 February 2018

Lynn M Veatch

series ordinal

3

1 reference

12 February 2018

publication date

24 April 2006

1 reference

12 February 2018

published in

Alcohol and Alcoholism

1 reference

12 February 2018

volume

41

1 reference

12 February 2018

issue

4

1 reference

12 February 2018

page(s)

399-406

1 reference

12 February 2018

Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Kindling as a Model for Alcohol Withdrawal Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Effects of lorazepam treatment for multiple ethanol withdrawals in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin pharmacology and its relevance to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin as adjunctive therapy for partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Polysomnographic and subjective sleep predictors of alcoholic relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

EEG sleep studies in “pure” primary alcoholism during subacute withdrawal: Relationships to normal controls, age, and other clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Long-term intracranial cannula stabilization in mice with light cured resin composites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Update on anticonvulsants for the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

New developments in the pharmacotherapy of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Basic mechanisms of generalized absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Activity profile of pregabalin in rodent models of epilepsy and ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Electrographic and behavioral indices of ethanol withdrawal sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGL029

21 January 2018

Identifiers

DOI

10.1093/ALCALC/AGL029

1 reference

12 February 2018

1 reference

12 February 2018